{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Eye-Connect: Podcast Channel","title":"Challenges in RVO Care","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/04910b2b\"></iframe>","width":"100%","height":180,"duration":1819,"description":"Please CLICK HERE (https://www.eye-connect.org/rvo/1403-1/) to review the CME information and complete the pretest for this activity.\nJoin host Dr Sridhar and guests Drs Ip and Bakri for a podcast highlighting the challenges in care of patients with macular edema secondary to retinal vein occlusion (RVO). With the American Academy of Ophthalmology RVO Preferred Practice Pattern as a guide, the faculty consider the current approach to treatment using anti-vascular endothelial growth factor (VEGF) agents and factors that may suggest a need for more intensive, long-term treatment. The anti-VEGF agents have been standard of care for over a decade; however, many patients need frequent injections to be effective. The anti-VEGF agents faricimab and aflibercept 8 mg have shown noninferior efficacy and greater durability in pivotal clinical trials at reducing patient treatment burden.\nWhen you are finished, please CLICK HERE to complete the posttest and evaluation.\nTRANSCRIPT\nREFERENCES ","thumbnail_url":"https://img.transistorcdn.com/MKKy7JjcDeIK3s13CJyo3OcQn3WQXVH-HFnfdEaytOM/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85ZTRl/MjI4ZDExYjJjNTcz/NWRiY2IwZjc1NGM2/NTcwMS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}